ProShares UltraShort Health Care
RXD
2 hedge funds and large institutions have $213K invested in ProShares UltraShort Health Care in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 3 closing their positions.
356% more call options, than puts
Call options by funds: $106M | Put options by funds: $23.4M
9.72% less ownership
Funds ownership: 26.93% → 17.21% (-9.7%)
38% less capital inflows, than outflows
Capital inflows: $218K | Capital outflows: $350K
50% less funds holding
Funds holding: 4 → 2 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IMC Chicago
Chicago,
Illinois
|
+$218K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
-$336K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$13.7K |
| 3 |
Simplex Trading
Chicago,
Illinois
|
-$405 |
RXD Hedge Fund Activity: Q2 2023 in Review
2 of the 6,387 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q2 2023, worth a combined $213K — down 39% from $350K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of RXD and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was IMC Chicago, opening a new position worth an estimated $218K. The largest seller was Envestnet Asset Management, exiting entirely with an estimated $336K sold.
- 2 institutional investors held ProShares UltraShort Health Care (RXD) as of Q2 2023, down from 4 in Q1 2023.
- Funds reported $213K of ProShares UltraShort Health Care stock for Q2 2023, down 39% quarter-over-quarter.
- 1 fund opened new ProShares UltraShort Health Care positions in Q2 2023 and 3 closed out, a net change of -2 holders.
- The largest ProShares UltraShort Health Care buyer in Q2 2023 was IMC Chicago, an estimated $218K added.
- The largest ProShares UltraShort Health Care seller in Q2 2023 was Envestnet Asset Management, an estimated $336K sold.
Based on aggregated 13F filings for Q2 2023.